A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors
Clinical trial NCT06417554 · RECRUITING
Trial details
- NCT number
- NCT06417554
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2027-07-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.